HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

H F Farag Selected Research

Triclabendazole

4/2011Evaluation of two doses of triclabendazole in treatment of patients with combined schistosomiasis and fascioliasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


H F Farag Research Topics

Disease

3Fascioliasis
04/2011 - 09/2000
2Schistosomiasis (Bilharziasis)
04/2011 - 09/2010
1Schistosomiasis mansoni
04/2011
1Infections
04/2011
1Persistent Infection
09/2000

Drug/Important Bio-Agent (IBA)

1TriclabendazoleIBA
04/2011
1Praziquantel (Biltricide)FDA Link
04/2011
1myrrh resin (myrrh)IBA
09/2010
1Pharmaceutical PreparationsIBA
09/2010
1Immunoglobulin G (IgG)IBA
09/2000

Therapy/Procedure

1Aftercare (After-Treatment)
04/2011